CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS

Company

Telix Pharmaceuticals Ltd

Filed

January 20, 2026

Period of Report

January 19, 2026

Accession Number

0002007191-26-000004